Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Novo Nordisk's PIONEER TEENS Trial: What Happened On April 23, 2026, Novo Nordisk announced positive topline results from PIONEER TEENS , a Phase 3a clinical trial that is historic in its scope: it marks the first time an oral GLP-1 receptor agonist (GLP-1 RA) has ever been evaluated in a pediatric population
Because melanin turnover is slow, you dont need continuous high plasma levels to maintain visible effects
It contains the active ingredient liraglutide, which works by mimicking the naturally occurring hormone GLP-1
This work was supported by a pilot grant from the HIV and Aging Grant CFAR-UAB (R24 AG044325), and a philanthropic donation received from the McNair Medical Institute at The Robert and Janice McNair Foundation.
Serious risks shared by both medications include: Thyroid C-cell tumors: Both carry an FDA boxed warning for an increased risk of thyroid tumors, including medullary thyroid carcinoma (MTC)
